glp 1 and blood clots Stop April 2025 PEP Talk: Weight,

pdp-big4

Initially designed for managing type 2 diabetes, these GLP-1 receptor agonists have proven so effective at curbing appetite that theyre now being prescribed off-label for weight loss

New regulations taking effect on 1 October 2024 will remove compounded semaglutide-containing products from the pharmacy compounding exemption

Your medication ships discreetly from a licensed compounding pharmacy on a monthly cadence

Simple, gentle at-home sample collection with CLIA lab processing and clear online results-designed for convenient check-ins from start to finish Comprehensive Biomarker Panel: Tracks four key wellness areas including liver function, lipid health with LDL, HDL, total cholesterol and triglycerides, kidney filtration with eGFR, Creatinine and BUN, plus pancreatic enzyme activity monitoring